Regorafenib
Regorafenib | |
---|---|
Term | Regorafenib |
Short definition | Regorafenib - (pronounced) (REH-goh-RA-feh feather) A drug used to treat certain types of colon cancer, gastrointestinal stromal tumors and hepatocellular carcinoma (a type of liver cancer). It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Regorafenib - (pronounced) (REH-goh-RA-feh feather) A drug used to treat certain types of colon cancer, gastrointestinal stromal tumors and hepatocellular carcinoma (a type of liver cancer). It is also being studied in the treatment of other types of cancer. Regorafenib blocks certain proteins that can prevent cancer cells from growing. It can also prevent the growth of new blood vessels that tumors need to grow. Regorafenib is a type of kinase inhibitor and a type of anti-angiogenesis drug. Also called Stivarga
External links
- Medical encyclopedia article on Regorafenib
- Wikipedia's article - Regorafenib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski